Sleep Apnea Devices Market Overview:
The Sleep Apnea Devices Market was valued at $5.5 billion in 2021 and is projected to grow at a CAGR of 7% through 2031. Growth is being driven by a substantial population of undiagnosed patients, increasing adoption of home-based sleep testing, supportive reimbursement policies in major markets such as the United States, rising awareness of the health risks associated with untreated sleep apnea, expanding funding initiatives to improve OSA diagnosis and treatment, and the entry of new companies into the space. However, limited patient adherence—particularly to CPAP therapy—remains a significant barrier to sustained market expansion.
Download Sample PDF Copy: https://meditechinsights.com/sleep-apnea-devices-market/request-sample/
Obstructive sleep apnea (OSA), the most prevalent type of sleep-disordered breathing (SDB), occurs when the upper airway partially or completely collapses due to relaxation of the soft palate and tongue muscles during sleep. Globally, an estimated one billion adults aged 30 to 69 are affected by OSA. The condition’s severity is assessed using the Apnea-Hypopnea Index (AHI), which measures the number of apnea or hypopnea events per hour:
- Normal: AHI < 5 events/hour
- Mild: 5 ≤ AHI < 15 events/hour
- Moderate: 15 ≤ AHI < 30 events/hour
- Severe: AHI ≥ 30 events/hour
OSA prevalence is steadily increasing and is estimated to affect approximately 3% to 20% of the general population.
Technological Advancements Driving Market Growth
The sleep apnea devices market is highly technology-driven, characterized by ongoing innovation and product enhancements. For example, in October 2021, AirAvant Medical launched Bongo Rx, a CPAP alternative designed to treat mild to moderate OSA. The device is inserted into the nostrils during sleep to maintain airflow by creating a seal as the user breathes.
In August 2021, ResMed introduced AirSense 11, its next-generation positive airway pressure (PAP) device. The system features tools such as the Personal Therapy Assistant and Care Check-In to provide customized guidance and improve therapy adherence. It also supports remote software updates, enabling patients to access the latest features without replacing the device.
In April 2021, Somne announced development of a non-invasive CPAP alternative worn around the neck. Using patented Variable Negative Pressure (UNEP) technology, the device delivers therapy during sleep without traditional airway masks.
Growing Shift Toward Home Sleep Apnea Testing (HSAT)
Traditionally, sleep apnea diagnosis required an overnight stay in a sleep laboratory, where multiple sensors were attached to monitor heart rate, brain activity, muscle movement, breathing patterns, and other physiological parameters. These studies were comprehensive but often costly and inconvenient.
Today, home sleep apnea testing (HSAT) is gaining popularity. HSAT is conducted outside of a hospital or sleep lab using a portable monitoring device that tracks sleep-related breathing parameters overnight. These tests are typically more affordable—ranging from approximately $200 to $600—compared to $800 to $3,000 for in-lab studies. HSAT also requires fewer sensors and allows patients to undergo testing in the comfort of their homes. Increasingly, insurers are requiring HSAT as an initial diagnostic step before approving coverage for in-lab testing.
Download Sample PDF Copy: https://meditechinsights.com/sleep-apnea-devices-market/request-sample/
Favorable Reimbursement Policies in Key Markets
In the United States, Medicare Part B covers diagnostic testing and treatment for OSA when established criteria are met. Covered diagnostic services include oximetry testing, polysomnography, in-lab sleep studies, and home sleep studies. Treatment options eligible for coverage include continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BiPAP) systems, respiratory assist devices, and mandibular advancement oral appliances. Such reimbursement support significantly enhances patient access and contributes to market growth.
Strategic Initiatives Strengthening Market Position
The competitive landscape includes both established players and emerging companies pursuing organic and inorganic growth strategies such as product launches, acquisitions, and partnerships.
For instance, in December 2021, ZOLL Medical Corporation acquired Itamar Medical Ltd., a company specializing in at-home sleep apnea diagnostics. In February 2021, GoPAPfree introduced the O2Vent Optima oral appliance, featuring integrated airway technology designed to improve therapy response rates and reduce snoring.
Browse Report: https://meditechinsights.com/sleep-apnea-devices-market/
Market Outlook and Competitive Landscape
The sleep apnea devices market is poised for sustained growth, supported by continuous technological innovation, increased awareness campaigns by governments and manufacturers, rising adoption of oral appliances due to their convenience and portability, and advancements such as compliance tracking and remote adjustment technologies that optimize airway patency over time.
Key companies operating in the market include ResMed, Philips Respironics, Fisher & Paykel Healthcare, SomnoMed, Itamar Medical, Inspire Medical Systems, Compumedics, Oventus Medical, Natus Medical, Drive DeVilbiss Healthcare, Whole You, and BMC Medical, among others.
Related Report:
Large Molecule Drug Substance CDMO Market https://www.pharmiweb.com/press-release/2026-02-25/large-molecule-drug-substance-cdmo-market-2026-size-share-trends-and-growth-by-forecast-2030
Pharmerging Market https://www.pharmiweb.com/press-release/2026-02-25/pharmerging-market-analysis-size-share-top-companies-and-research-report-by-2029
Artificial Intelligence (AI) in Drug Discovery Market https://www.pharmiweb.com/press-release/2026-02-25/artificial-intelligence-ai-in-drug-discovery-market-size-growth-and-forecast-2025-2029
Radioligand Therapy (RLT) Market https://www.pharmiweb.com/press-release/2026-02-25/radioligand-therapy-rlt-market-research-report-analysis-size-share-trends-and-forecast-2030
Medical Tourism Market https://www.pharmiweb.com/press-release/2026-02-25/medical-tourism-market-research-report-analysis-size-share-trends-and-forecast-2029
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
